|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:54-61, doi:10.1016/j.jacc.2004.06.079 © 2005 by the American College of Cardiology Foundation |



,
,

* Bioengineering, Rice University, Houston, Texas
Cardiovascular Medicine
Biostatistics
Kaufman Center for Heart Failure
|| Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, Ohio
Manuscript received January 30, 2004; revised manuscript received May 10, 2004, accepted May 11, 2004.
* Reprint requests and correspondence: Dr. K. Jane Grande-Allen, Department of Bioengineering, MS 142, Rice University, PO Box 1892, Houston, Texas 77251-1892 (Email: grande{at}rice.edu).
OBJECTIVES: This study assessed apparently normal mitral valves from patients with congestive heart failure (CHF) using biochemical and echocardiographic measures of extracellular matrix (ECM) and anatomy.
BACKGROUND: Mitral regurgitation (MR) is frequently found in patients with CHF. This MR is considered purely functional, yet animal studies suggest that altered left ventricular (LV) function leads to increased cellularity and fibrosis of the mitral valve. Therefore, we hypothesized that patients with CHF might have partly organic MR, via dysfunctional valvular remodeling.
METHODS: Mitral valves from transplant recipient hearts of patients with CHF (23 dilated, 14 ischemic) were analyzed for deoxyribonucleic acid (DNA), collagen, glycosaminoglycan (GAG), and water concentrations and compared with autopsy controls. Cardiac dimensions and functional parameters (measured from recent echocardiograms) were compared with biochemical parameters using a repeated measures generalized linear model.
RESULTS: The mitral valves in CHF had up to 78% more DNA (p < 0.03), 59% more GAGs (p < 0.02), and 15% more collagen (p < 0.007), but 7% less water (p < 0.05) than normal. The absence of anterior leaflet redundancy was associated with these deranged biochemical measures (p < 0.03). Associations were found between leaflet thickness and DNA concentration (+, p = 0.003), annular diameter and chordal collagen (+, p = 0.03), and water concentration and both left atrial diameter (, p = 0.008) and LV collagen concentration (, p = 0.04).
CONCLUSIONS: Mitral valves in CHF are biochemically different from normal, with ECM changes that are influenced by the altered cardiac dimensions. This remodeling suggests that MR in patients with CHF may not be purely functional, and that these valves are not "normal."
| ||||||||||||
This article has been cited by other articles:
![]() |
E. H. Stephens, T. C. Nguyen, A. Itoh, N. B. Ingels Jr, D. C. Miller, and K. J. Grande-Allen The Effects of Mitral Regurgitation Alone Are Sufficient for Leaflet Remodeling Circulation, September 30, 2008; 118(14_suppl_1): S243 - S249. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Gillam Is It Time to Update the Definition of Functional Mitral Regurgitation?: Structural Changes in the Mitral Leaflets With Left Ventricular Dysfunction Circulation, August 19, 2008; 118(8): 797 - 799. [Full Text] [PDF] |
||||
![]() |
M. Chaput, M. D. Handschumacher, F. Tournoux, L. Hua, J. L. Guerrero, G. J. Vlahakes, and R. A. Levine Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation Circulation, August 19, 2008; 118(8): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.M. Fedak, P. M. McCarthy, and R. O. Bonow Evolving Concepts and Technologies in Mitral Valve Repair Circulation, February 19, 2008; 117(7): 963 - 974. [Full Text] [PDF] |
||||
![]() |
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374. [Full Text] [PDF] |
||||
![]() |
T. A. Timek, D. T. Lai, P. Dagum, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Mitral Leaflet Remodeling in Dilated Cardiomyopathy Circulation, July 4, 2006; 114(1_suppl): I-518 - I-523. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Caira, S. R. Stock, T. G. Gleason, E. C. McGee, J. Huang, R. O. Bonow, T. C. Spelsberg, P. M. McCarthy, S. H. Rahimtoola, and N. M. Rajamannan Human Degenerative Valve Disease Is Associated With Up-Regulation of Low-Density Lipoprotein Receptor-Related Protein 5 Receptor-Mediated Bone Formation J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1707 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas Highlights of the Year in JACC 2005 J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202. [Full Text] [PDF] |
||||
![]() |
K. J. Grande-Allen, J. E. Barber, K. M. Klatka, P. L. Houghtaling, I. Vesely, C. S. Moravec, and P. M. McCarthy Mitral valve stiffening in end-stage heart failure: Evidence of an organic contribution to functional mitral regurgitation J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. O'Brien and D. P. Fishbein Mitral valve abnormalities in congestive heart failure: An interplay between form and function? J. Am. Coll. Cardiol., January 4, 2005; 45(1): 62 - 64. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |